111 related articles for article (PubMed ID: 36919844)
1. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study.
Brooks JD; Mah A; Christensen RAG; Arneja J; Eisen A; Chiarelli AM
Genet Med; 2023 Jun; 25(6):100820. PubMed ID: 36919844
[TBL] [Abstract][Full Text] [Related]
2. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
3. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
4. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
[TBL] [Abstract][Full Text] [Related]
5. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
[TBL] [Abstract][Full Text] [Related]
6. Screening women at high risk for breast cancer: one program fits all? : Subgroup analysis of a large population high risk breast screening program.
Hermann N; Klil-Drori A; Angarita FA; Westergard S; Freitas V; Scaranelo A; McCready DR; Cil TD
Breast Cancer Res Treat; 2020 Dec; 184(3):763-770. PubMed ID: 32851453
[TBL] [Abstract][Full Text] [Related]
7. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
9. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40-49 years - could it be better?
Oblak T; Zadnik V; Krajc M; Lokar K; Zgajnar J
Radiol Oncol; 2020 Jul; 54(3):335-340. PubMed ID: 32614783
[TBL] [Abstract][Full Text] [Related]
12. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
Ghoncheh M; Ziaee F; Karami M; Poorolajal J
Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
Loehberg CR; Jud SM; Haeberle L; Heusinger K; Dilbat G; Hein A; Rauh C; Dall P; Rix N; Heinrich S; Buchholz S; Lex B; Reichler B; Adamietz B; Schulz-Wendtland R; Beckmann MW; Fasching PA
Breast Cancer Res Treat; 2010 May; 121(1):101-10. PubMed ID: 20306293
[TBL] [Abstract][Full Text] [Related]
14. Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.
Lo LL; Milne RL; Liao Y; Cuzick J; Terry MB; Phillips KA
Br J Cancer; 2018 Jul; 119(1):36-39. PubMed ID: 29925933
[TBL] [Abstract][Full Text] [Related]
15. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
[TBL] [Abstract][Full Text] [Related]
16. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
18. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a breast cancer risk prediction model for Thai women: a cross-sectional study.
Anothaisintawee T; Teerawattananon Y; Wiratkapun C; Srinakarin J; Woodtichartpreecha P; Hirunpat S; Wongwaisayawan S; Lertsithichai P; Kasamesup V; Thakkinstian A
Asian Pac J Cancer Prev; 2014; 15(16):6811-7. PubMed ID: 25169530
[TBL] [Abstract][Full Text] [Related]
20. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
